» Articles » PMID: 6496992

The Involvement of Endotoxin in Halothane-associated Liver Injury

Overview
Journal Anesthesiology
Specialty Anesthesiology
Date 1984 Nov 1
PMID 6496992
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Since endotoxin, lipopolysaccharides (LPS), have been implicated as a causative factor in the development of hepatic necrosis in rats exposed to hepatotoxic levels of several chemical agents, the role of LPS in the halothane-hypoxia (HH) model of hepatic damage in male Sprague-Dawley rats was investigated. When injected intravenously immediately after halothane anesthesia, a subnecrotic dose of LPS (0.5 mg/kg; Escherichia coli 026:B6) was found to markedly potentiate HH-induced hepatic necrosis. Pretreatment of the animals with the antiendotoxin agent, lactulose, prior to exposure to halothane reduced the hepatic damage normally seen from HH. A possible mechanism of LPS-induced potentiation was indicated by changes in hepatic calcium levels at 24 h after treatment. Endogenous LPS may play a role in HH-induced hepatic necrosis, and the mechanism of LPS-induced potentiation may be due to an LPS-related membrane dysfunction.

Citing Articles

Chitohexaose protects against acetaminophen-induced hepatotoxicity in mice.

Barman P, Mukherjee R, Prusty B, Suklabaidya S, Senapati S, Ravindran B Cell Death Dis. 2016; 7:e2224.

PMID: 27171266 PMC: 4917664. DOI: 10.1038/cddis.2016.131.


A mouse model of severe halothane hepatitis based on human risk factors.

Dugan C, MacDonald A, Roth R, Ganey P J Pharmacol Exp Ther. 2010; 333(2):364-72.

PMID: 20124411 PMC: 2872951. DOI: 10.1124/jpet.109.164541.